NCT00752141

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 153 (actual)
• Sponsor: Watson Pharmaceuticals · Industry
• Sex: All
• Age: 60 Years – 79 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	oxybutynin chloride immediate-release	capsule containing oxybutynin chloride immediate-release 5 mg tablet administered three times daily, and placebo gel administered once daily
DRUG	oxybutynin chloride topical gel	oxybutynin chloride topical gel applied once daily, and capsule containing placebo tablet administered three times daily
OTHER	placebo	capsule containing placebo tablet administered three times daily, and placebo gel administered once daily

Timeline

• Start date: 2008-09-01
• Primary completion: 2008-10-01
• First posted: 2008-09-15
• Last updated: 2011-09-23

Locations

6 sites across 1 country: United States